{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T23:24:32Z","timestamp":1780701872667,"version":"3.54.1"},"reference-count":158,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.reprotox.2003.10.014","type":"journal-article","created":{"date-parts":[[2004,1,27]],"date-time":"2004-01-27T05:23:12Z","timestamp":1075180992000},"page":"219-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta)"],"prefix":"10.1016","volume":"18","author":[{"given":"Shelly Tartakover","family":"Matalon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asher","family":"Ornoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lishner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2003.10.014_BIB1","first-page":"367","article-title":"Aging and reproductive potential in women","volume":"71","author":"Fitzgerald","year":"1998","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB2","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/1097-0142(19941001)74:7+<1995::AID-CNCR2820741702>3.0.CO;2-Y","article-title":"Cancer in older persons. Magnitude of the problem-how do we apply what we know?","volume":"74","author":"Yancik","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00041552-200111000-00006","article-title":"Progress in the clinical application of immunosuppressive drugs in renal transplantation","volume":"10","author":"Wilkinson","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00003088-199528030-00005","article-title":"Placental transfer of drugs administered to the mother","volume":"28","author":"Pacifici","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archinte.1992.00400150093017","article-title":"Fetal outcome after in utero exposure to cancer chemotherapy","volume":"152","author":"Zemlickis","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB6","first-page":"462","article-title":"Teratogenic effects of first trimester cyclophosphamide therapy","volume":"72","author":"Kirshon","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/tcm.1770130304","article-title":"Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide","volume":"13","author":"Zemlickis","year":"1993","journal-title":"Teratog Carcinog Mutagen"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/tera.1420410405","article-title":"Experimental manipulation of the rodent visceral yolk sac","volume":"41","author":"Beckman","year":"1990","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB9","doi-asserted-by":"crossref","first-page":"13055","DOI":"10.1073\/pnas.162468499","article-title":"Teratogenicity induced by targeting a placental immunoglobulin transporter","volume":"99","author":"Kolonin","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/plac.1999.0450","article-title":"To be, or not to be, that is the question. Apoptosis in human trophoblast","volume":"21","author":"Levy","year":"2000","journal-title":"Placenta"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0301-2115(95)02261-9","article-title":"Apoptosis: programmed cell death in fetal development","volume":"64","author":"Haanen","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1365-2249.1999.00986.x","article-title":"Colony-stimulating factor-1 (CSF-1) expression in the uteroplacental unit of mice with spontaneous and induced pregnancy loss","volume":"117","author":"Gorivodsky","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/plac.1999.0501","article-title":"TNF-alpha\/TNFRI in primary and immortalized first trimester cytotrophoblasts","volume":"21","author":"Knofler","year":"2000","journal-title":"Placenta"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0026-895X(24)13482-7","article-title":"6-Meracaptopurine decreases the Bcl-2\/Bax ratio and induces apoptosis in activated splenic B lymphocytes","volume":"51","author":"Hortelano","year":"1997","journal-title":"Mol Pharm"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1600-0897.1998.tb00430.x","article-title":"TNF-alpha expression in embryos exposed to a teratogen","volume":"40","author":"Ivnitsky","year":"1998","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/(SICI)1098-2795(199701)46:1<54::AID-MRD9>3.0.CO;2-Q","article-title":"Role of colony-stimulating factor-1 in reproduction and development","volume":"46","author":"Pollard J","year":"1997","journal-title":"Mol Reprod Dev"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB17","unstructured":"Physicians desk reference. Medical economic data, a division of medical economics company. Montvale; 1993."},{"key":"10.1016\/j.reprotox.2003.10.014_BIB18","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/humupd\/7.4.384","article-title":"Cancer in pregnancy: maternal and fetal implications","volume":"7","author":"Weisz","year":"2001","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/humupd\/7.4.394","article-title":"Genetic and teratogenic effects of cancer treatments on gametes and embryos","volume":"7","author":"Arnon","year":"2001","journal-title":"Human Reprod Update"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/gast.2003.50014","article-title":"Present DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease a retrospective cohort study","volume":"124","author":"Francella","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1096-8628(19990917)86:3<237::AID-AJMG8>3.0.CO;2-V","article-title":"Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype?","volume":"86","author":"Enns","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3816\/CLM.2001.n.023","article-title":"Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero","volume":"2","author":"Aviles","year":"2001","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00003088-200038040-00001","article-title":"Metabolism and pharmacokinetics of oxazaphosphorines","volume":"38","author":"Alan","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB24","first-page":"5629","article-title":"Differential activation of cyclophosphamide and isophamide by cytochromes P-450 2B and 3A in human liver microsomes","volume":"53","author":"Cang","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB25","doi-asserted-by":"crossref","unstructured":"Hakkolaa J, Raunioa H, Purkunenb R, Pelkonena O, Saarikoskib S, Cresteilc T, Pasanena M. Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem Pharmacol 1996;52:379\u201383.","DOI":"10.1016\/0006-2952(96)00216-X"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10408449891344173","article-title":"Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity","volume":"28","author":"Hakkola","year":"1998","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB27","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1071\/RD9951521","article-title":"Human placental cytochrome P450 and quinone reductase enzyme induction in relation to maternal smoking","volume":"7","author":"Boden","year":"1995","journal-title":"Reprod Fertil Dev"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/15287399509532035","article-title":"Induction of cytochrome P-450 in the Norway rat, Rattus norvegicus, following exposure to potential environmental contaminants","volume":"46","author":"Nims","year":"1995","journal-title":"J Toxicol Environ Health"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB29","first-page":"1946","article-title":"Enhanced cyclophosphamide and isofamide activation in primary human hepatocyte cultures: response to cytochrome P-450 inducers and autoinduction by oxazaphosphorines","volume":"57","author":"Chang","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0027-5107(96)00200-X","article-title":"Induction of DNA crosslinks and DNA strand lesions by cyclophosphamide after activation by cytochrome P450 2B1","volume":"373","author":"Hengstler","year":"1997","journal-title":"Mutat Res."},{"key":"10.1016\/j.reprotox.2003.10.014_BIB31","first-page":"5029","article-title":"Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells","volume":"46","author":"Crook","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000047187","article-title":"In utero exposure to immunosuppressive drugs","volume":"81","author":"Prevot","year":"2002","journal-title":"Biol Neonate"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2174\/0929867003374769","article-title":"Apoptosis at the interface of immunosuppressive and anticancer activities: the examples of two classes of chemical inducers","volume":"7","author":"Bischoff","year":"2000","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB34","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1124\/mol.60.6.1268","article-title":"Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells","volume":"60","author":"Schwartz","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/tera.1420500102","article-title":"Role of apoptosis in mediating phosphoramide mustard-induced rat embryo malformations in vitro","volume":"50","author":"Chen","year":"1994","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0940-2993(98)80085-7","article-title":"Cyclophosphamide-induced generation of reactive oxygen species. Comparison with morphological changes in type II alveolar epithelial cells and lung capillaries","volume":"50","author":"Sulkowska","year":"1998","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/toxsci\/57.1.6","article-title":"The molecular effects of acrolein","volume":"57","author":"Kehrer","year":"2000","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB38","first-page":"1681","article-title":"Transplacental passage of cyclophosphamide","volume":"66","author":"D\u2019Incalci","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB39","first-page":"475","article-title":"Teratogenicity of cyclophosphamide in mice","volume":"28","author":"Gibson","year":"1968","journal-title":"Cancer Res"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB40","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0013-9351(83)90007-5","article-title":"Embryopathic effects of cyclophosphamide","volume":"31","author":"Gilani","year":"1983","journal-title":"Environ Res"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/tcm.1770050202","article-title":"Cyclophosphamide teratogenesis: a review","volume":"5","author":"Mirkes","year":"1985","journal-title":"Terat Carcin Mutagen"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/tera.1420420504","article-title":"Cyclophosphamide teratogenesis: evidance for compensatory responses to induced cellular toxicity","volume":"42","author":"Francis","year":"1990","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/tera.1420030310","article-title":"The embryolethal and teratogenic effects of Cyclophosphamide on mouse embryos","volume":"3","author":"Gebhardt","year":"1970","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB44","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/tera.1420150311","article-title":"Influence of cyclophosphamide and 4-keto-cyclophosphamide on mouse limb development","volume":"15","author":"Manason","year":"1977","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB45","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3109\/17453678408992414","article-title":"Forelimb malformation in rats caused by cyclophosphamide","volume":"55","author":"Jeyaseelan","year":"1984","journal-title":"Acta Orthop Scand"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/316144a0","article-title":"Paternal cyclophosphamide treatment of rats causes fetal loss and malformations without affecting male fertility","volume":"316","author":"Trasler","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB47","first-page":"363","article-title":"Teratogenic effects of cyclophosphamide in the rat","volume":"51","author":"Chaube","year":"1967","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB48","first-page":"477","article-title":"Aspects of the teratology of cyclophosphamide","volume":"60","author":"Ashby","year":"1976","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000145888","article-title":"Congenital anomalies of the ear resulting from cyclophosphamide treatment in the rat","volume":"119","author":"Padmanabhan","year":"1984","journal-title":"Acta Anat"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01990086","article-title":"Effects of cyclophosphamide on embryonic development in the rabbit","volume":"2","author":"Fritz","year":"1971","journal-title":"Agents Actions"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB51","first-page":"248","article-title":"Induction of craniofacial malformations in the rhesus monkey with cyclophosphamide","volume":"16","author":"Mcclure","year":"1979","journal-title":"Cleft Palate J"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB52","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM198511073131901","article-title":"A study of occupational exposure to antineoplastic drugs and fetal loss in nurses","volume":"313","author":"Selevan","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB53","unstructured":"Motherisk, source for evidence-based information about the safety or risk of drugs, chemicals and disease during pregnancy and lactation. In: Koren G, Lishner M, site directors. www.motherisk.org."},{"key":"10.1016\/j.reprotox.2003.10.014_BIB54","doi-asserted-by":"crossref","unstructured":"Greenberg T. Congenital anomalies probably induced by cyclophosphamide. JAMA 1964;188:423\u201326.","DOI":"10.1001\/jama.1964.03060310023005"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7326\/0003-4819-74-1-87","article-title":"Fetal effects during cyclophosphamide and irradiation therapy","volume":"74","author":"Toledo","year":"1971","journal-title":"Ann Int Med"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1479-828X.1970.tb03304.x","article-title":"Cyclophosphamide in pregnancy","volume":"10","author":"Coates","year":"1970","journal-title":"Aust NZ J Obstet Gynecol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB57","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1001\/jama.1984.03350180061032","article-title":"Multimodal cancer therapy for breast cancer in the first trimester of pregnancy","volume":"252","author":"Murray","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB58","first-page":"462","article-title":"Teratogenic effects of first trimester cyclophosphamide therapy","volume":"72","author":"Kirshon","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/tcm.1770130304","article-title":"Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide","volume":"13","author":"Zemlickis","year":"1993","journal-title":"Teratog Carcinog Mutagen"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB60","first-page":"825","article-title":"Two normal pregnancies in patients receiving cytoxan for Hodgkin\u2019s disease","volume":"88","author":"Marazzini","year":"1966","journal-title":"Ann Obstet Gynecol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB61","first-page":"679","article-title":"Treatment of acute leukemia during pregnancy: presentation of nine cases","volume":"64","author":"Pizzuto","year":"1980","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB62","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mpo.2950070405","article-title":"Acute leukemia in pregnancy: transient neonatal myelosuppression after combination therapy in the mother","volume":"7","author":"Okun","year":"1979","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB63","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/tcm.1770050203","article-title":"The embryotoxicity of cyclophosphamide in rabbits during the histiotrophic phase of nutrition","volume":"5","author":"Claussen","year":"1985","journal-title":"Teratog Carcinog Mutagen"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB64","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/bdra.10005","article-title":"Teratogen-induced activation of the mitochondrial apoptotic pathway in the yolk sac of day 9 mouse embryos","volume":"67","author":"Soleman","year":"2003","journal-title":"Birth Defects Res Part A Clin Mol Teratol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB65","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1677\/joe.0.1590069","article-title":"Effects of colony stimulating factor-1 on human extravillous trophoblast growth and invasion","volume":"159","author":"Hamilton","year":"1998","journal-title":"J Endocrinol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB66","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.4049\/jimmunol.160.9.4280","article-title":"TNF-alpha messenger RNA and protein expression in the uteroplacental unit of mice with pregnancy loss","volume":"160","author":"Gorivodsky","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB67","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1023\/A:1020541019347","article-title":"The role of apoptosis in normal and abnormal embryonic development","volume":"16","author":"Brill","year":"1999","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB68","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1023\/A:1021740108284","article-title":"TNF-alpha in pregnancy loss and embryo maldevelopment: a mediator of detrimental stimuli or a protector of the fetoplacental unit?","volume":"20","author":"Toder","year":"2003","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB69","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0897.1999.tb00476.x","article-title":"TGF beta 2 mRNA expression and pregnancy failure in mice","volume":"42","author":"Gorivodsky","year":"1999","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB70","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1567-5769(01)00183-7","article-title":"Maternal immune stimulation in mice decreases fetal malformations caused by teratogens","volume":"2","author":"Holladay","year":"2002","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/(SICI)1520-6866(1999)19:3<171::AID-TCM1>3.0.CO;2-S","article-title":"A possible role for granulocyte macrophage-colony stimulating factor in modulating teratogen-induced effects","volume":"19","author":"Savion","year":"1999","journal-title":"Teratog Carcinog Mutagen"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB72","unstructured":"Herken R, Eibs HG, Spielmann H. Decidual changes in the rat following cyclophosphamide treatment before implantation. Bibl Anat 1981:247\u201357."},{"key":"10.1016\/j.reprotox.2003.10.014_BIB73","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/tcm.1770060205","article-title":"Maternal administration of cyclophosphamide induces chromosomal aberrations and inhibits cell number, histone synthesis, and DNA synthesis in preimplantation mouse embryos","volume":"6","author":"Kola","year":"1986","journal-title":"Teratog Carcinog Mutagen"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB74","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/014850199262878","article-title":"Cyclophosphamide modulates gene expression in neonatal rat testis following antenatal exposure to fetuses during testicular differentiation","volume":"42","author":"Saxena","year":"1999","journal-title":"Arch Androl"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB75","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/tera.10100","article-title":"Role of caspases in murine limb bud cell death induced by 4-hydroperoxycyclophosphamide, an activated analog of cyclophosphamide","volume":"66","author":"Huang","year":"2002","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB76","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1242\/dev.125.16.3225","article-title":"The role of p53 and cell death by apoptosis and necrosis in 4-hydroperoxycyclophosphamide-induced limb malformations","volume":"125","author":"Moallem","year":"1998","journal-title":"Development"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB77","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/00001756-200105250-00020","article-title":"Induction of cytokine expression in the brain macrophages\/amoeboid microglia of the fetal rat exposed to a teratogen","volume":"12","author":"Hao","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB78","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1034\/j.1600-0897.2002.1o027.x","article-title":"Apoptosis in the uterus of mice with pregnancy loss","volume":"47","author":"Savion","year":"2002","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB79","first-page":"101","article-title":"The effects of cytostatic agents\u2014methotrexate, actinomycin-D and cyclophosphamide\u2014on in vitro metabolism of human placenta from early pregnancy","volume":"186","author":"Nagy","year":"1982","journal-title":"Z Geburtshilfe Perinatol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB80","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jmg.29.2.109","article-title":"Cyclophosphamide increases the frequency of sister chromatid exchange in direct preparations of human chorionic villi in the absence of supplementary enzymatic activation systems","volume":"29","author":"Pariani","year":"1992","journal-title":"J Med Genet"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB81","unstructured":"Shaffer Ch, editor. Drugs during pregnancy and lactation. Elsevier; 2001. p. 162\u201381."},{"key":"10.1016\/j.reprotox.2003.10.014_BIB82","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/ctrv.2002.0245","article-title":"Continuing therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of methotrexate, 6-mercaptopurine and 6 thioguanine","volume":"27","author":"Estlin","year":"2001","journal-title":"Anc Treat Re"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB83","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-3565(25)39054-3","article-title":"Human lymphocyte thiopurine methyltransferase pharmacogenetics: effect of phenotype on 6-mercaptopurine-induced inhibition of mitogen stimulation","volume":"242","author":"Van Loon","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB84","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0143-4004(88)90070-7","article-title":"Activities of key enzymes of purine degradation and re-utilization in human trophoblastic cells","volume":"9","author":"Vettenranta","year":"1988","journal-title":"Placenta"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB85","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000457495","article-title":"Thiopurine methyltransferase in humans: development and tissue distribution","volume":"17","author":"Pacifici","year":"1991","journal-title":"Dev Pharmacol Ther"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB86","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1242\/dev.124.16.3089","article-title":"Genetically engineered mice demonstrate that adenosine deaminase is essential for early postimplantation development","volume":"124","author":"Blackburn","year":"1997","journal-title":"Development"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/tera.1420490103","article-title":"Activation of apoptosis in early mouse embryos by 2\u2032-deoxyadenosine exposure","volume":"49","author":"Gao","year":"1994","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB88","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s004410051289","article-title":"2\u2032-Deoxyadenosine causes cell death in embryonic chicken sympathetic ganglia and brain","volume":"296","author":"Zhao","year":"1999","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB89","unstructured":"Mathews CK, van Holde KE. Biochemistry. Redwood City, CA: The Benjamin\/Cummings Publishing Company; 1990."},{"key":"10.1016\/j.reprotox.2003.10.014_BIB90","first-page":"1071","article-title":"Inhibition studies on membrane adenosine deaminase from human placenta","volume":"46","author":"Lupidi","year":"1998","journal-title":"Biochem Mol Biol Int"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB91","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0009-2797(94)90086-8","article-title":"DNA modification induced by 6-mercaptopurine riboside in murine embryos","volume":"93","author":"Platzek","year":"1994","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB92","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/0002-9378(73)90559-0","article-title":"Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus","volume":"115","author":"Saarikoski","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB93","first-page":"713","article-title":"The effect of imuran on implantation and early embryonic development in rats","volume":"50","author":"Gross","year":"1977","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB94","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(65)80071-3","article-title":"Teratogenic effects of azathioprine (Imuran)","volume":"66","author":"Githens","year":"1965","journal-title":"J Pediatr"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB95","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0002-9378(67)90503-0","article-title":"Azathioprine (Imuran) and pregnancy","volume":"97","author":"Rosenkrantz","year":"1967","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB96","first-page":"1984","article-title":"Considerations surles tests teratogenes. Differences de reaction de trios especes animals a Iegard un antitumoral","volume":"158","author":"Tuchmann-Duplessis","year":"1964","journal-title":"CRSBA"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB97","first-page":"393","article-title":"A study of maternal lymphoid organs and the progeny following treatment with immunomodulating agents during pregnancy","volume":"30","author":"Scott","year":"1977","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB98","doi-asserted-by":"crossref","unstructured":"Murphy ML. Teratogenic effects of tumor-inhibiting chemicals in therat. In: Wolstenholme GEW, Oconner CM, editors. A CIBA Foundation symposium on congenital malformations, London, p. 78.","DOI":"10.1002\/9780470715277.ch5"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB99","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3181\/00379727-116-29345","article-title":"Teratogenesis: effects of substituted purines and the influence of 4 hydroxypyrazolopyrimidine in the rat","volume":"116","author":"Bragonier","year":"1964","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB100","first-page":"181","article-title":"The teratogenic effects of the recent drugs active in cancer chemotherapy","volume":"3","author":"Chaub","year":"1968","journal-title":"Adv Teratol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB101","first-page":"395","article-title":"Teratogenic effects of some purine analogues on fetal rat","volume":"86","author":"Kury","year":"1968","journal-title":"Arch Pathol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB102","first-page":"762","article-title":"Obtenion de malformations des members par la6-mercaptopurine chez trios especes lapin, rat et souris","volume":"161","author":"Mercier-parot","year":"1967","journal-title":"C R Seances Soc Biol Fil"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB103","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1439-0442.1975.tb01403.x","article-title":"Etude de la sesibilite embryonnaire de l\u2019ochotone afghan (Ochotona rufesscens rufescens) a deux agents tertogenes, l\u2019zathioprine et la 6 mercaptopurine","volume":"22","author":"Puget","year":"1975","journal-title":"Zentralbl Veterinarmed"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB104","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1749-6632.1954.tb40012.x","article-title":"The effect of 6 mercaptopurine on the rat fetus and on reproduction of the rat","volume":"60","author":"Theirch","year":"1954","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0300-483X(84)90151-3","article-title":"Monitoring of organ formation in rat embryos after in vitro exposure to azathioprine, mercaptopurine, methotrexate or cyclosporin","volume":"31","author":"Schmid","year":"1984","journal-title":"Toxicology"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB106","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00467-001-0776-z","article-title":"In utero exposure to IS drugs experimental and clinical studies","volume":"17","author":"Tendron","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB107","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1046\/j.1365-2036.2003.01537.x","article-title":"Azathioprine, mercaptopurine and birth outcome: a population-based cohort study","volume":"17","author":"Norgard","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB108","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1471-0528.1993.tb15205.x","article-title":"Preganacy after reanal transplantation: 25 years experience in spain","volume":"100","author":"Cararach","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB109","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3109\/00016348609158386","article-title":"Pregnancy following kidney transplantation","volume":"65","author":"Marushak","year":"1986","journal-title":"Acta Obstet Gyecol Scand"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02973400","article-title":"Outcome of pregnancy following renal transplantation","volume":"160","author":"Brown","year":"1991","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB111","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/03009742.1998.11720785","article-title":"Drug treatment of rheumatic diseases during pregnancy. The teratogenicity of antirheumatic drugs-What is the evidence?","volume":"27","author":"Kallen","year":"1998","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB112","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ki.1980.130","article-title":"Parenthood following renal transplantation","volume":"18","author":"Penn","year":"1980","journal-title":"Kidney Int"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB113","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00007890-197604000-00004","article-title":"Immunosuppressive drugs and the foetus","volume":"21","author":"Price","year":"1976","journal-title":"Transplantation"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB114","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/tera.10043","article-title":"Teratogen update: azathioprine and 6-mercaptopurine","volume":"65","author":"Polifka","year":"2002","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1542\/peds.25.1.85","article-title":"Transplacental transmission of busulfan in a mother with leukemia","volume":"25","author":"Diamond","year":"1960","journal-title":"Pediatrics"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB116","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/1097-0142(19870901)60:5<1143::AID-CNCR2820600537>3.0.CO;2-E","article-title":"Pregnancy outcome in cancer patients. Experience in a large cooperative group","volume":"60","author":"Mulvihill","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB117","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.2830360404","article-title":"Growth and development of children of mothers treated with chemotherapy during pregnancy. Current status of 43 children","volume":"36","author":"Aviles","year":"1991","journal-title":"Am J Hematol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB118","unstructured":"Nishimura H, Tanimura T. Clinical aspects of the teratogenicity of drugs. NY: Elsevier; 1976. p. 106\u201397."},{"key":"10.1016\/j.reprotox.2003.10.014_BIB119","doi-asserted-by":"crossref","unstructured":"Burleson RL. Renal allotransplantation during pregnancy. Successful outcome for mother, child, and kidney. Transplantation 1983:334\u201336.","DOI":"10.1097\/00007890-198309000-00020"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ajmg.a.10817","article-title":"Is immunosuppression therapy in renal allograft recipients teratogenic? A single-center experience","volume":"116A","author":"Bar","year":"2003","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB121","first-page":"442","article-title":"Successful pregnancy after orthotopic liver transplantation","volume":"74","author":"Haagsma","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB122","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0002-9378(93)90127-5","article-title":"Pregnancy after cardiac transplantation","volume":"169","author":"Baxi","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB123","first-page":"1773","article-title":"Thirty successful pregnancies in organ transplant recipients: a single-center experimence","volume":"26","author":"Talaat","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB124","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0016-5085(90)91027-4","article-title":"Safety of AZA in pregnancy in inflammatory bowel disease","volume":"99","author":"Alstead","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/096120339600500205","article-title":"Factors associated with fetal loss in severe systemic lupus erythematosus","volume":"5","author":"Martinez-Rueda","year":"1996","journal-title":"Lupu"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB126","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/gast.2003.50014","article-title":"Present DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study","volume":"124","author":"Francella","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB127","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1046\/j.1365-2036.2003.01537.x","article-title":"Azathioprine, mercaptopurine and birth outcome: a population-based cohort study","volume":"17","author":"Norgard","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB128","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0022-3476(84)80435-7","article-title":"Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone","volume":"105","author":"DeWitte","year":"1984","journal-title":"J Pediatr"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/pgmj.49.569.211","article-title":"A neonatal complication of maternal leukemia treated with 6-mercaptopurine","volume":"49","author":"McConnel","year":"1973","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB130","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1056\/NEJM198712243172614","article-title":"Chromosomal aberrations in a newborn whose mother received cytotoxic treatment during pregnancy","volume":"317","author":"Schleuning","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB131","doi-asserted-by":"crossref","unstructured":"Attenuating effect of zinc on abnormal placental morphology in 6-mercaptopurine treated rats. Teratology 1978;17:315\u201325.","DOI":"10.1002\/tera.1420170310"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB132","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2165\/00003088-200241060-00004","article-title":"Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs","volume":"41","author":"Danesi","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB133","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/abbi.1996.0096","article-title":"Oxidized aldose reductase: in vivo factor not in vitro artifact","volume":"327","author":"Grimshaw","year":"1996","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB134","first-page":"491","article-title":"Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity","volume":"1","author":"Muller","year":"1998","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB135","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","article-title":"A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin","volume":"57","author":"Gewirtz","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB136","first-page":"595","article-title":"Transplacental passage of doxorubicin","volume":"18","author":"Grohard","year":"1989","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB137","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/030089169207800513","article-title":"Weekly doxorubicin chemotherapy for breast cancer in pregnancy. A case report","volume":"78","author":"Barni","year":"1992","journal-title":"Tumori"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB138","first-page":"773","article-title":"Doxorubicin in pregnancy: possible transplacental passage","volume":"67","author":"Karp","year":"1983","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB139","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(83)91614-8","article-title":"Transplacental passage of doxorubicin","volume":"1","author":"D\u2019Incalci","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB140","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/jpsu.2002.32262","article-title":"Midgut atresias result from abnormal development of the notochord in an Adriamycin rat model","volume":"37","author":"Gillick","year":"2002","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB141","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/tcm.1016","article-title":"Teratogenic effects of doxorubicin in rats at midgestation and at term","volume":"21","author":"Menegola","year":"2001","journal-title":"Teratog Carcinog Mutagen"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB142","first-page":"1152","article-title":"Toxicological studies on adriamycin-HCl. 4. Tertological study","volume":"6","author":"Oguro","year":"1973","journal-title":"Yakubutsu Ryoho (Med. Treat.)"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB143","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/(SICI)1097-0185(199810)252:2<271::AID-AR12>3.0.CO;2-K","article-title":"Embryogenesis of tracheal atresia","volume":"252","author":"Merei","year":"1998","journal-title":"Anat. Rec."},{"key":"10.1016\/j.reprotox.2003.10.014_BIB144","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/tera.1420170207","article-title":"Teratogenicity of adryamyin and daunomycin in the rat and rabbit","volume":"17","author":"Thompson","year":"1978","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB145","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/jpsu.2002.32262","article-title":"Midgut atresias result from abnormal development of the notochord in an adriamycin rat model","volume":"37","author":"Gillick","year":"2002","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB146","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1053\/jpsu.2000.18331","article-title":"Temporospatial aberrations of apoptosis in the rat embryo developing esophageal atresia","volume":"35","author":"Williams","year":"2000","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB147","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF02439273","article-title":"Effects of antitumor drugs on offspring","volume":"129","author":"Gol\u2019dberg","year":"2000","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB148","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/tera.1420310210","article-title":"Embryotoxic effects of doxorubicin and N-trifluroacetyladriamycin-14- valerate (AD-32)","volume":"31","author":"Zirvi","year":"1985","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB149","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1001\/jama.1984.03350180061032","article-title":"Multimodal cancer therapy for breast cancer in the first trimester of pregnancy. A case report","volume":"252","author":"Murray","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB150","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0022-3468(99)90390-1","article-title":"Apoptosis in tracheoesophageal embryogenesis in rat embryos with or without adriamycin treatment","volume":"34","author":"Zhou","year":"1999","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB151","first-page":"101","article-title":"Apoptosis in preimplantation mammalian embryo and genetics","volume":"106","author":"Levy","year":"2001","journal-title":"Ital J Anat Embryol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB152","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1023\/A:1013728012048","article-title":"Alteration of the Bcl-2: Bax ratio in the placenta as pregnancy proceeds","volume":"33","author":"De Falco","year":"2001","journal-title":"Histochem J"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB153","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1677\/joe.0.1590069","article-title":"Effects of colony stimulating factor-1 on human extravillous trophoblast growth and invasion","volume":"159","author":"Hamilton","year":"1998","journal-title":"J Endocrinol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB154","doi-asserted-by":"crossref","unstructured":"Pollard. Role of colony-stimulating factor 1 in reproduction and development. Mol Reprod Dev 1997;46:54\u201360.","DOI":"10.1002\/(SICI)1098-2795(199701)46:1<54::AID-MRD9>3.0.CO;2-Q"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB155","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/labinvest.3780334","article-title":"Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta","volume":"81","author":"Tarrade","year":"2001","journal-title":"Lab Invest"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB156","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1071-5576(00)00091-5","article-title":"Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome","volume":"8","author":"Shaarawy","year":"2001","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB157","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-0378(93)90054-L","article-title":"TGF-beta 2 gene and protein expression in maternal and fetal tissues at various stages of murine development","volume":"25","author":"Cheng","year":"1993","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.reprotox.2003.10.014_BIB158","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1139\/y02-016","article-title":"Regulation of human trophoblast migration and invasiveness","volume":"80","author":"Chakraborty","year":"2002","journal-title":"Can J Physiol Pharmacol"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623803001631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623803001631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:20:46Z","timestamp":1760188846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623803001631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":158,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0890623803001631"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2003.10.014","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta)","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2003.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}